- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Flotation/IPO
Exits: May 24, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
May 24, 2022Microba makes tracks to ASX
The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.
Apr 7, 2022Exits: February 7, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Feb 7, 2022SenseTime scores $851m in initial public offering
The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.
Dec 31, 2021Exits: November 26, 2021
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Nov 26, 2021Entrada Therapeutics enters Nasdaq
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Nov 11, 2021Pyxis progresses to stock market
Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.
Oct 11, 2021Exscientia expands IPO to over $350m
The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.
Oct 7, 2021Other News
Pyxis picks price range
UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.
Oct 5, 2021Exscientia establishes Nasdaq listing
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
Oct 4, 2021Li-S Energy celebrates market debut
Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.
Sep 30, 2021Lucid Diagnostics lines up IPO
Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.
Sep 28, 2021Oxford Nanopore sets IPO plans in motion
Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.
Sep 21, 2021Editor's Picks
McBride moves along to M12
M12, a Microsoft Venture Fund, has hired Jason McBride as a partner, after working as the corporation's director of business development for two years
Oct 17, 2022Porsche's IPO follows CVC activity
In the run-up to the float, Porche's investment arm had invested in 18 companies, from hypercars to EV batteries and even bikes.
Oct 1, 2022The Standout Six: The deals you need to know about this week
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
Aug 26, 2022Deezer agrees $1.1bn reverse merger
The audio streaming service is set to list with help from a PIPE deal featuring Orange, Access Industries, Warner Music, UMG and Media Participations.
Apr 20, 2022About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.